Hydantoin derivatives and malignancies of the haemopoietic system.
Two patients are described who developed malignant lymphoma (lymphosarcoma) after diphenylydantoin therapy because of epilepsy. Malignant lymphoma in a few patients receiving this medication has been described earlier. The literature has been reviewed and discussed recently by Rausing and Trell (2).